CDEK
← All organizations
Oyster Point Pharma, Inc.

Oyster Point Pharma, Inc.

For profitWebsite ↗

Also known as: OYSTER POINT PHARMA | Oyster Point Pharma, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Feb 27, 2018

First marketed drug

Oct 15, 2021

Last known activity

May 1, 2023

Acquired by Viatris → Meda Pharmaceuticals → Mylan on Nov 7, 2022

Timeline

2010s

  1. Jul 1, 2015

    Oyster Point Pharma, Inc.— Founded

  2. Feb 10, 2016

    Mylan— Now

2020s

  1. Oct 15, 2021

    varenicline— Marketing Organization

  2. Oct 15, 2021

    varenicline— NDA Secondary Org

  3. Nov 7, 2022

    Viatris— Acquired By

Drugs by trial phase (2 distinct, 12 trials)

Phase 4 (1 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (12)

Details

Founded
San Francisco, CA, US Jul 1, 2015
Last known activity
May 1, 2023